Litcius/Paper detail

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

Marianne Weulersse, Assia Asrir, Andrea Pichler, L Lemaître, Matthias Braun, Nadège Carrié, Marie-Véronique Joubert, Marie Le Moine, Laura Do Souto, Guillaume Gaud, Indrajit Das, Elisa Brauns, Clara‐Maria Scarlata, Elena Morandi, Ashmitha Sundarrajan, Marine Cuisinier, Laure Buisson, Sabrina Mahéo, Sahar Kassem, Arantxa Agesta, Michaël Pérès, Els Verhoeyen, Alejandra Martínez, Julien Mazières, Loı̈c Dupré, Thomas Gossye, Véra Pancaldi, Camille Guillerey, Maha Ayyoub, Anne S. Dejean, Abdelhadi Saoudi, Stanislas Goriely, Hervé Avet‐Loiseau, Tobias Bald, Mark J. Smyth, Ludovic Martinet

2020Immunity139 citationsDOIOpen Access PDF

Topics & Concepts

BiologyCD8Cancer immunotherapyCytotoxic T cellImmunotherapyCancer researchT-cell receptorCell biologyTumor microenvironmentImmune systemReceptorT cellImmunologyBiochemistryIn vitroImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersCAR-T cell therapy research